English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 136 | Tables: 136 | Medical Care
The global Monoclonal Mouse Antibody market was valued at US$ 10150 million in 2025 and is anticipated to reach US$ 13570 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Monoclonal Mouse Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.
This report delivers a comprehensive overview of the global Monoclonal Mouse Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Monoclonal Mouse Antibody. The Monoclonal Mouse Antibody market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Monoclonal Mouse Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Monoclonal Mouse Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Others
by Application
Therapeutic
Research
Diagnostic
ELISA kits
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Monoclonal Mouse Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Monoclonal Mouse Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Monoclonal Mouse Antibody Market Overview
1.1 Product Definition
1.2 Monoclonal Mouse Antibody by Type
1.2.1 Global Monoclonal Mouse Antibody Market Value by Type: 2025 vs 2032
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Others
1.3 Monoclonal Mouse Antibody by Application
1.3.1 Global Monoclonal Mouse Antibody Market Value by Application: 2025 vs 2032
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.3.5 ELISA kits
1.4 Global Monoclonal Mouse Antibody Market Size Estimates and Forecasts
1.4.1 Global Monoclonal Mouse Antibody Revenue 2021–2032
1.4.2 Global Monoclonal Mouse Antibody Sales 2021–2032
1.4.3 Global Monoclonal Mouse Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Monoclonal Mouse Antibody Market Competition by Manufacturers
2.1 Global Monoclonal Mouse Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Monoclonal Mouse Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Monoclonal Mouse Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Monoclonal Mouse Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Monoclonal Mouse Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Monoclonal Mouse Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Monoclonal Mouse Antibody, Date of Entry into the Industry
2.8 Global Monoclonal Mouse Antibody Market Competitive Situation and Trends
2.8.1 Global Monoclonal Mouse Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Monoclonal Mouse Antibody Players Market Share by Revenue
2.8.3 Global Monoclonal Mouse Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Monoclonal Mouse Antibody Market Scenario by Region
3.1 Global Monoclonal Mouse Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Monoclonal Mouse Antibody Sales by Region: 2021–2032
3.2.1 Global Monoclonal Mouse Antibody Sales by Region: 2021–2026
3.2.2 Global Monoclonal Mouse Antibody Sales by Region: 2027–2032
3.3 Global Monoclonal Mouse Antibody Revenue by Region: 2021–2032
3.3.1 Global Monoclonal Mouse Antibody Revenue by Region: 2021–2026
3.3.2 Global Monoclonal Mouse Antibody Revenue by Region: 2027–2032
3.4 North America Monoclonal Mouse Antibody Market Facts & Figures by Country
3.4.1 North America Monoclonal Mouse Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Monoclonal Mouse Antibody Sales by Country (2021–2032)
3.4.3 North America Monoclonal Mouse Antibody Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Monoclonal Mouse Antibody Market Facts & Figures by Country
3.5.1 Europe Monoclonal Mouse Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Monoclonal Mouse Antibody Sales by Country (2021–2032)
3.5.3 Europe Monoclonal Mouse Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monoclonal Mouse Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Monoclonal Mouse Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Monoclonal Mouse Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Monoclonal Mouse Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Monoclonal Mouse Antibody Market Facts & Figures by Country
3.7.1 Latin America Monoclonal Mouse Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Monoclonal Mouse Antibody Sales by Country (2021–2032)
3.7.3 Latin America Monoclonal Mouse Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monoclonal Mouse Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Monoclonal Mouse Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Monoclonal Mouse Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Monoclonal Mouse Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Monoclonal Mouse Antibody Sales by Type (2021–2032)
4.1.1 Global Monoclonal Mouse Antibody Sales by Type (2021–2026)
4.1.2 Global Monoclonal Mouse Antibody Sales by Type (2027–2032)
4.1.3 Global Monoclonal Mouse Antibody Sales Market Share by Type (2021–2032)
4.2 Global Monoclonal Mouse Antibody Revenue by Type (2021–2032)
4.2.1 Global Monoclonal Mouse Antibody Revenue by Type (2021–2026)
4.2.2 Global Monoclonal Mouse Antibody Revenue by Type (2027–2032)
4.2.3 Global Monoclonal Mouse Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Monoclonal Mouse Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Monoclonal Mouse Antibody Sales by Application (2021–2032)
5.1.1 Global Monoclonal Mouse Antibody Sales by Application (2021–2026)
5.1.2 Global Monoclonal Mouse Antibody Sales by Application (2027–2032)
5.1.3 Global Monoclonal Mouse Antibody Sales Market Share by Application (2021–2032)
5.2 Global Monoclonal Mouse Antibody Revenue by Application (2021–2032)
5.2.1 Global Monoclonal Mouse Antibody Revenue by Application (2021–2026)
5.2.2 Global Monoclonal Mouse Antibody Revenue by Application (2027–2032)
5.2.3 Global Monoclonal Mouse Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Monoclonal Mouse Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Monoclonal Mouse Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck Monoclonal Mouse Antibody Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novartis Monoclonal Mouse Antibody Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 AbbVie Monoclonal Mouse Antibody Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Company Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Amgen Monoclonal Mouse Antibody Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Monoclonal Mouse Antibody Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bayer Monoclonal Mouse Antibody Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Company Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Lilly Monoclonal Mouse Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Company Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Company Information
6.11.2 GlaxoSmithKline Description and Business Overview
6.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Company Information
6.12.2 Biogen Description and Business Overview
6.12.3 Biogen Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Biogen Monoclonal Mouse Antibody Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Company Information
6.13.2 AstraZeneca Description and Business Overview
6.13.3 AstraZeneca Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 AstraZeneca Monoclonal Mouse Antibody Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Sanofi Monoclonal Mouse Antibody Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Company Information
6.15.2 Alexion Pharmaceuticals Description and Business Overview
6.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Company Information
6.16.2 Seattle Genetics Description and Business Overview
6.16.3 Seattle Genetics Monoclonal Mouse Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monoclonal Mouse Antibody Industry Chain Analysis
7.2 Monoclonal Mouse Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monoclonal Mouse Antibody Production Mode & Process Analysis
7.4 Monoclonal Mouse Antibody Sales and Marketing
7.4.1 Monoclonal Mouse Antibody Sales Channels
7.4.2 Monoclonal Mouse Antibody Distributors
7.5 Monoclonal Mouse Antibody Customer Analysis
8 Monoclonal Mouse Antibody Market Dynamics
8.1 Monoclonal Mouse Antibody Industry Trends
8.2 Monoclonal Mouse Antibody Market Drivers
8.3 Monoclonal Mouse Antibody Market Challenges
8.4 Monoclonal Mouse Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Monoclonal Mouse Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Monoclonal Mouse Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Monoclonal Mouse Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global Monoclonal Mouse Antibody Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Monoclonal Mouse Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Monoclonal Mouse Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Monoclonal Mouse Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Monoclonal Mouse Antibody Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Monoclonal Mouse Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Monoclonal Mouse Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Monoclonal Mouse Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of Monoclonal Mouse Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Mouse Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Monoclonal Mouse Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monoclonal Mouse Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Monoclonal Mouse Antibody Sales by Region (K Units), 2021–2026
Table 18. Global Monoclonal Mouse Antibody Sales Market Share by Region (2021–2026)
Table 19. Global Monoclonal Mouse Antibody Sales by Region (K Units), 2027–2032
Table 20. Global Monoclonal Mouse Antibody Sales Market Share by Region (2027–2032)
Table 21. Global Monoclonal Mouse Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global Monoclonal Mouse Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global Monoclonal Mouse Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global Monoclonal Mouse Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America Monoclonal Mouse Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Monoclonal Mouse Antibody Sales by Country (K Units), 2021–2026
Table 27. North America Monoclonal Mouse Antibody Sales by Country (K Units), 2027–2032
Table 28. North America Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Monoclonal Mouse Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Monoclonal Mouse Antibody Sales by Country (K Units), 2021–2026
Table 32. Europe Monoclonal Mouse Antibody Sales by Country (K Units), 2027–2032
Table 33. Europe Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Monoclonal Mouse Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Monoclonal Mouse Antibody Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Monoclonal Mouse Antibody Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Monoclonal Mouse Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Monoclonal Mouse Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Monoclonal Mouse Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Monoclonal Mouse Antibody Sales by Country (K Units), 2021–2026
Table 42. Latin America Monoclonal Mouse Antibody Sales by Country (K Units), 2027–2032
Table 43. Latin America Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Monoclonal Mouse Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Monoclonal Mouse Antibody Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Monoclonal Mouse Antibody Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Monoclonal Mouse Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global Monoclonal Mouse Antibody Sales (K Units) by Type (2021–2026)
Table 51. Global Monoclonal Mouse Antibody Sales (K Units) by Type (2027–2032)
Table 52. Global Monoclonal Mouse Antibody Sales Market Share by Type (2021–2026)
Table 53. Global Monoclonal Mouse Antibody Sales Market Share by Type (2027–2032)
Table 54. Global Monoclonal Mouse Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Monoclonal Mouse Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global Monoclonal Mouse Antibody Price (USD/Unit) by Type (2021–2026)
Table 59. Global Monoclonal Mouse Antibody Price (USD/Unit) by Type (2027–2032)
Table 60. Global Monoclonal Mouse Antibody Sales (K Units) by Application (2021–2026)
Table 61. Global Monoclonal Mouse Antibody Sales (K Units) by Application (2027–2032)
Table 62. Global Monoclonal Mouse Antibody Sales Market Share by Application (2021–2026)
Table 63. Global Monoclonal Mouse Antibody Sales Market Share by Application (2027–2032)
Table 64. Global Monoclonal Mouse Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Monoclonal Mouse Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global Monoclonal Mouse Antibody Price (USD/Unit) by Application (2021–2026)
Table 69. Global Monoclonal Mouse Antibody Price (USD/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Roche Monoclonal Mouse Antibody Product
Table 74. Roche Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Johnson & Johnson Monoclonal Mouse Antibody Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Merck Monoclonal Mouse Antibody Product
Table 84. Merck Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Novartis Monoclonal Mouse Antibody Product
Table 89. Novartis Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. AbbVie Monoclonal Mouse Antibody Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Amgen Company Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Amgen Monoclonal Mouse Antibody Product
Table 99. Amgen Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Monoclonal Mouse Antibody Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Bayer Company Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Bayer Monoclonal Mouse Antibody Product
Table 109. Bayer Recent Developments/Updates
Table 110. Lilly Company Information
Table 111. Lilly Description and Business Overview
Table 112. Lilly Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Lilly Monoclonal Mouse Antibody Product
Table 114. Lilly Recent Developments/Updates
Table 115. Bristol-Myers Squibb Company Information
Table 116. Bristol-Myers Squibb Description and Business Overview
Table 117. Bristol-Myers Squibb Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Bristol-Myers Squibb Monoclonal Mouse Antibody Product
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. GlaxoSmithKline Company Information
Table 121. GlaxoSmithKline Description and Business Overview
Table 122. GlaxoSmithKline Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. GlaxoSmithKline Monoclonal Mouse Antibody Product
Table 124. GlaxoSmithKline Recent Developments/Updates
Table 125. Biogen Company Information
Table 126. Biogen Description and Business Overview
Table 127. Biogen Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Biogen Monoclonal Mouse Antibody Product
Table 129. Biogen Recent Developments/Updates
Table 130. AstraZeneca Company Information
Table 131. AstraZeneca Description and Business Overview
Table 132. AstraZeneca Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. AstraZeneca Monoclonal Mouse Antibody Product
Table 134. AstraZeneca Recent Developments/Updates
Table 135. Sanofi Company Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Sanofi Monoclonal Mouse Antibody Product
Table 139. Sanofi Recent Developments/Updates
Table 140. Alexion Pharmaceuticals Company Information
Table 141. Alexion Pharmaceuticals Description and Business Overview
Table 142. Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. Alexion Pharmaceuticals Monoclonal Mouse Antibody Product
Table 144. Alexion Pharmaceuticals Recent Developments/Updates
Table 145. Seattle Genetics Company Information
Table 146. Seattle Genetics Description and Business Overview
Table 147. Seattle Genetics Monoclonal Mouse Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 148. Seattle Genetics Monoclonal Mouse Antibody Product
Table 149. Seattle Genetics Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Monoclonal Mouse Antibody Distributors List
Table 153. Monoclonal Mouse Antibody Customers List
Table 154. Monoclonal Mouse Antibody Market Trends
Table 155. Monoclonal Mouse Antibody Market Drivers
Table 156. Monoclonal Mouse Antibody Market Challenges
Table 157. Monoclonal Mouse Antibody Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Monoclonal Mouse Antibody
Figure 2. Global Monoclonal Mouse Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Monoclonal Mouse Antibody Market Share by Type: 2025 & 2032
Figure 4. IgM Product Picture
Figure 5. IgG Product Picture
Figure 6. IgA Product Picture
Figure 7. Others Product Picture
Figure 8. Global Monoclonal Mouse Antibody Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Monoclonal Mouse Antibody Market Share by Application: 2025 & 2032
Figure 10. Therapeutic
Figure 11. Research
Figure 12. Diagnostic
Figure 13. ELISA kits
Figure 14. Global Monoclonal Mouse Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Monoclonal Mouse Antibody Market Size (US$ Million), 2021–2032
Figure 16. Global Monoclonal Mouse Antibody Sales (K Units), 2021–2032
Figure 17. Global Monoclonal Mouse Antibody Average Price (USD/Unit), 2021–2032
Figure 18. Monoclonal Mouse Antibody Report Years Considered
Figure 19. Monoclonal Mouse Antibody Sales Share by Manufacturers in 2025
Figure 20. Global Monoclonal Mouse Antibody Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Monoclonal Mouse Antibody Players: Market Share by Revenue in Monoclonal Mouse Antibody in 2025
Figure 22. Monoclonal Mouse Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Monoclonal Mouse Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Monoclonal Mouse Antibody Sales Market Share by Country (2021–2032)
Figure 25. North America Monoclonal Mouse Antibody Revenue Market Share by Country (2021–2032)
Figure 26. U.S. Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Monoclonal Mouse Antibody Sales Market Share by Country (2021–2032)
Figure 29. Europe Monoclonal Mouse Antibody Revenue Market Share by Country (2021–2032)
Figure 30. Germany Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Monoclonal Mouse Antibody Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Monoclonal Mouse Antibody Revenue Market Share by Region (2021–2032)
Figure 37. China Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Taiwan Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Indonesia Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Thailand Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Malaysia Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Philippines Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Monoclonal Mouse Antibody Sales Market Share by Country (2021–2032)
Figure 48. Latin America Monoclonal Mouse Antibody Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Monoclonal Mouse Antibody Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Monoclonal Mouse Antibody Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. U.A.E Monoclonal Mouse Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Monoclonal Mouse Antibody by Type (2021–2032)
Figure 58. Global Revenue Market Share of Monoclonal Mouse Antibody by Type (2021–2032)
Figure 59. Global Monoclonal Mouse Antibody Price (USD/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Monoclonal Mouse Antibody by Application (2021–2032)
Figure 61. Global Revenue Market Share of Monoclonal Mouse Antibody by Application (2021–2032)
Figure 62. Global Monoclonal Mouse Antibody Price (USD/Unit) by Application (2021–2032)
Figure 63. Monoclonal Mouse Antibody Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
